Insider Transactions in Q1 2025 at Sage Therapeutics, Inc. (SAGE)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 24
2025
|
Gregory L. Shiferman |
SELL
Payment of exercise price or tax liability
|
Direct |
79
-0.26%
|
$632
$8.21 P/Share
|
|
Feb 24
2025
|
Gregory L. Shiferman |
SELL
Payment of exercise price or tax liability
|
Direct |
2,502
-7.52%
|
$17,514
$7.49 P/Share
|
|
Feb 13
2025
|
Gregory L. Shiferman |
SELL
Payment of exercise price or tax liability
|
Direct |
627
-0.93%
|
$4,389
$7.18 P/Share
|
|
Feb 13
2025
|
Laura Gault Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
685
-1.94%
|
$4,795
$7.18 P/Share
|
|
Feb 13
2025
|
Christopher Benecchi Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
822
-1.84%
|
$5,754
$7.18 P/Share
|
|
Jan 16
2025
|
Christopher Benecchi Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+30.89%
|
-
|
|
Jan 16
2025
|
Laura Gault Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,000
+40.45%
|
-
|
|
Jan 16
2025
|
Gregory L. Shiferman |
BUY
Grant, award, or other acquisition
|
Direct |
14,000
+29.23%
|
-
|